{"id":"https://openalex.org/W3034360599","doi":"https://doi.org/10.2337/db20-926-p","title":"926-P: Cardiovascular (CV) and Hypoglycemia Outcomes across Age Groups in People with Type 2 Diabetes (T2D) in the CAROLINA Trial","display_name":"926-P: Cardiovascular (CV) and Hypoglycemia Outcomes across Age Groups in People with Type 2 Diabetes (T2D) in the CAROLINA Trial","publication_year":2020,"publication_date":"2020-06-01","ids":{"openalex":"https://openalex.org/W3034360599","doi":"https://doi.org/10.2337/db20-926-p","mag":"3034360599"},"language":"en","primary_location":{"id":"doi:10.2337/db20-926-p","doi":"https://doi.org/10.2337/db20-926-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-926-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067354051","display_name":"Mark Andrew Espeland","orcid":"https://orcid.org/0000-0002-3711-1949","observed_orcids":["https://orcid.org/0000-0002-3711-1949"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARK ESPELAND","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059098934","display_name":"Richard E. Pratley","orcid":"https://orcid.org/0000-0002-2912-1389","observed_orcids":["https://orcid.org/0000-0002-2912-1389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RICHARD E. PRATLEY","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JULIO ROSENSTOCK","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040548657","display_name":"Takashi Kadowaki","orcid":"https://orcid.org/0000-0002-5428-3582","observed_orcids":["https://orcid.org/0000-0002-5428-3582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TAKASHI KADOWAKI","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052412166","display_name":"Yutaka Seino","orcid":"https://orcid.org/0000-0002-1099-7989","observed_orcids":["https://orcid.org/0000-0002-1099-7989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"YUTAKA SEINO","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090437675","display_name":"Bernard Zinman","orcid":"https://orcid.org/0000-0002-0041-1876","observed_orcids":["https://orcid.org/0000-0002-0041-1876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BERNARD ZINMAN","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019976194","display_name":"Nikolaus Marx","orcid":"https://orcid.org/0000-0001-6141-634X","observed_orcids":["https://orcid.org/0000-0001-6141-634X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"NIKOLAUS MARX","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071945904","display_name":"Darren K. McGuire","orcid":"https://orcid.org/0000-0002-6412-7989","observed_orcids":["https://orcid.org/0000-0002-6412-7989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DARREN K. MCGUIRE","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101082719","display_name":"Knut Robert Andersen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KNUT R. ANDERSEN","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081837566","display_name":"Michaela Mattheus","orcid":"https://orcid.org/0000-0002-8611-6236","observed_orcids":["https://orcid.org/0000-0002-8611-6236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MICHAELA MATTHEUS","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027179206","display_name":"Annett Keller","orcid":"https://orcid.org/0009-0002-3698-020X","observed_orcids":["https://orcid.org/0009-0002-3698-020X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANNETT KELLER","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008842761","display_name":"Odd Erik Johansen","orcid":"https://orcid.org/0000-0003-2470-0530","observed_orcids":["https://orcid.org/0000-0003-2470-0530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ODD ERIK JOHANSEN","raw_affiliation_strings":["Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winston-Salem, NC, Orlando, FL, Dallas, TX, Tokyo, Japan, Osaka, Japan, Toronto, ON, Canada, Aachen, Germany, Ingelheim, Germany, Asker, Norway","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09633813,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":0.9309999942779541},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.7820000052452087},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/weight-change","display_name":"weight change","score":0.45399999618530273},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7839999794960022},{"id":"https://openalex.org/keywords/age-subgroups","display_name":"age subgroups","score":0.6290000081062317},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8429999947547913},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.7519999742507935},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9179999828338623},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.5830000042915344},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.7599999904632568},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9950000047683716},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7319999933242798},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.8180000185966492},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8553886413574219},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.7067714333534241},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.6983708143234253},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.6972492933273315},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.558811366558075},{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.5072659850120544},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.49054187536239624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46415719389915466},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.44311511516571045},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.4284648299217224},{"id":"https://openalex.org/C2780739214","wikidata":"https://www.wikidata.org/wiki/Q6723023","display_name":"Mace","level":4,"score":0.4251467287540436},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.3442016839981079},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3252524137496948},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.15606683492660522},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.07062926888465881},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db20-926-p","doi":"https://doi.org/10.2337/db20-926-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db20-926-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3101372907","https://openalex.org/W3034422222","https://openalex.org/W3034241534","https://openalex.org/W3005025016","https://openalex.org/W3108521091","https://openalex.org/W1997515162","https://openalex.org/W4390546438","https://openalex.org/W4318166198","https://openalex.org/W3037244176","https://openalex.org/W4210509327"],"abstract_inverted_index":{"Older":[0],"people":[1],"with":[2,47,71,151],"T2D":[3,42],"have":[4],"a":[5,179,185],"high":[6],"prevalence":[7],"of":[8,17,37,103],"comorbidities,":[9],"frailty":[10],"and":[11,53,57,85,107,118,139,146,156,168,184,223,281,464,505,576,624,627],"polypharmacy.":[12],"We":[13],"investigated":[14],"the":[15,33,201],"effects":[16],"linagliptin":[18],"(LINA)":[19],"5":[20],"mg":[21,26],"versus":[22],"glimepiride":[23],"(GLIM)":[24],"1-4":[25],"once":[27],"daily":[28],"across":[29,119,140,158,173],"age":[30,91,120,159,174],"groups":[31,116],"in":[32,41,82,132,182],"CARdiovascular":[34],"Outcome":[35],"Study":[36],"LINAgliptin":[38],"Versus":[39],"Glimepiride":[40],"(CAROLINA\u00ae).":[43],"CAROLINA\u00ae":[44],"recruited":[45],"adults":[46],"relatively":[48],"early":[49],"T2D,":[50],"HbA1c":[51,133],"6.5-8.5%,":[52],"elevated":[54],"CV":[55,62,106,167],"risk":[56,144],"its":[58],"primary":[59],"outcome":[60],"was":[61],"death,":[63],"non-fatal":[64,68],"myocardial":[65],"infarction,":[66],"or":[67],"stroke":[69],"(3P-MACE),":[70],"secondary":[72],"outcomes":[73,109,170],"including":[74],"mortality":[75,108,169],"as":[76,78],"well":[77],"change":[79],"from":[80],"baseline":[81],"HbA1c,":[83],"weight":[84,147,183],"hypoglycemia.":[86],"Of":[87],"6033":[88],"patients":[89],"(median":[90],"64":[92],"[range":[93],"36-85]),":[94],"846":[95],"(14.0%)":[96],"were":[97,135,148,171],"\u226575":[98],"years.":[99],"During":[100],"median":[101],"follow-up":[102],"6.3":[104],"years,":[105],"rates":[110],"did":[111],"not":[112],"differ":[113],"between":[114,137],"treatment":[115],"overall":[117,155],"categories":[121],"(interaction":[122],"p-values":[123],">0.05).":[124],"Over":[125],"time,":[126],"following":[127],"some":[128],"initial":[129],"dynamics,":[130],"changes":[131],"levels":[134],"comparable":[136],"treatment-groups":[138],"age,":[141],"but":[142,176],"hypoglycemia":[143,188],"(Fig)":[145],"significantly":[149,186],"lower":[150,187],"LINA":[152,177],"vs.":[153],"GLIM":[154],"consistently":[157],"groups.":[160],"These":[161],"data":[162],"demonstrate":[163],"that":[164],"results":[165],"for":[166,200],"consistent":[172],"subgroups,":[175],"has":[178],"modest":[180],"benefit":[181],"burden":[189],"than":[190],"GLIM,":[191],"which":[192],"are":[193],"important":[194],"safety":[195],"considerations":[196],"when":[197],"selecting":[198],"therapy":[199],"elderly.":[202],"Disclosure":[203],"M.":[204,602],"Espeland:":[205],"Other":[206,217,270,402,521,563],"Relationship;":[207,218,271,403,522,564],"Self;":[208,219,250,272,296,331,404,413,461,497,523,553,565,608,616],"Boehringer":[209,275,338,418,432,478,499,528,567,609,617,622],"Ingelheim":[210,276,339,419,433,479,500,529,568,610,618,623],"International":[211,420,501,530,611,619],"GmbH,":[212,421,502,531],"Ironwood":[213],"Pharmaceuticals.":[214],"R.E.":[215],"Pratley:":[216],"AstraZeneca,":[220,251,525,566],"Eli":[221,279,346,422,466,503,574,625],"Lilly":[222,280,347,423,467,504,575,626],"Company,":[224,282,352,465,506,577],"GlaxoSmithKline":[225,256,581],"plc.,":[226,257,582],"Glytec,":[227],"Janssen":[228,285,507,583],"Scientific":[229],"Affairs,":[230],"LLC.,":[231],"Lexicon":[232,258,586],"Pharmaceuticals,":[233,259,262,277,286,340,508,569,584,587],"Inc.,":[234,241,244,255,260,267,278,287,290,299,335,341,438,484,509,517,537,548,570,580,585,588,592,597],"Ligand":[235],"Pharmaceuticals":[236],"Incorporated,":[237],"Merck":[238,426,472,510,539,557,589],"&":[239,428,474,512,541,559,590],"Co.,":[240,264,317,323,357,380,389,393,441,446,450,487,572,591],"Novo":[242,288,311,374,436,482,515,544,593],"Nordisk":[243,289,312,375,437,483,516,545,594],"Sanofi.":[245,291],"J.":[246],"Rosenstock:":[247],"Research":[248,294,411,535],"Support;":[249,295,412],"Bristol-Myers":[252],"Squibb,":[253],"Genentech,":[254],"Oramed":[261],"PegBio":[263],"Ltd.,":[265,314,318,324,353,358,377,381,390,394,417,435,442,447,451,481,488,573],"Pfizer":[266,547,596],"REMD":[268],"Biotherapeutics.":[269],"Applied":[273,555],"Therapeutics,":[274,284,556,579],"Intarcia":[283],"T.":[292],"Kadowaki:":[293],"Astellas":[297,333],"Pharma":[298,304,309,313,322,334,364,372,376,388,445],"Daiichi":[300,344,532],"Sankyo,":[301,345,533],"Mitsubishi":[302,362],"Tanabe":[303,363],"Corporation,":[305,307,343,365,367,370,471],"MSD":[306,366],"Novartis":[308,371],"K.K.,":[310,337,349,373,425,469],"Ono":[315,378,439],"Pharmaceutical":[316,326,379,392,396,440,449,453,486,490],"Sanofi,":[319,382],"Sumitomo":[320,386,443],"Dainippon":[321,387,444],"Takeda":[325,395,452,489],"Company":[327,397,454,491,628],"Limited.":[328,492],"Speaker\u2019s":[329,459],"Bureau;":[330,460],"Abbott,":[332,498],"AstraZeneca":[336],"Cosmic":[342],"Japan":[348,424,468],"FUJIFILM,":[350],"Kowa":[351,534],"Kyowa":[354],"Hakko":[355],"Kirin":[356],"Medscape":[359],"Education,":[360],"Medtronic,":[361,538],"NIPRO":[368],"Medical":[369,400,457],"Sanwa":[383],"Kagaku":[384],"Kenkyusho,":[385],"Taisho":[391,448,485],"Limited,":[398,455],"Terumo":[399,456],"Corporation.":[401,458],"Asahi":[405],"Mutual":[406],"Life":[407],"Insurance.":[408],"Y.":[409],"Seino:":[410],"ARKRAY,":[414],"Bayer":[415,526],"Yakuhin,":[416],"Sharp":[427,473,511,540,558],"Dohme":[429,475,513,542,560],"Corp.,":[430,476,514,543,561],"Nippon":[431,477],"Co.":[434,480],"Becton,":[462],"Dickinson":[463],"Kao":[470],"B.":[493],"Zinman:":[494],"Advisory":[495],"Panel;":[496],"Sanofi-Aventis.":[518,549,598],"N.":[519],"Marx:":[520],"Amgen,":[524],"Vital,":[527],"Institute,":[536],"A/S,":[546,595],"D.K.":[550],"McGuire:":[551],"Consultant;":[552],"Afimmune,":[554],"Metavant.":[562],"Eisai":[571],"Esperion":[578],"K.R.":[599],"Andersen:":[600],"None.":[601,604],"Mattheus:":[603],"A.":[605],"Keller:":[606],"Employee;":[607,615],"GmbH.":[612,620],"O.":[613],"Johansen:":[614],"Funding":[621],"Diabetes":[629],"Alliance":[630]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-06-19T00:00:00"}